Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF-kappaB signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease
As senescent cells seemed to be primed for ferroptosis, we reasoned that protective mechanisms against ferroptosis must be upregulated in senescent cells
No commercial use
Glutathione: pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
Lane DJR, Ayton S, Bush AI (2018) Iron and Alzheimers disease: an update on emerging mechanisms
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
US$ 26.70
US$ 26.95
US$ 25.02
US$ 25.74
US$ 20.08
US$ 23.50
